scispace - formally typeset
J

Johanneke Kleinnijenhuis

Researcher at Radboud University Nijmegen

Publications -  19
Citations -  3688

Johanneke Kleinnijenhuis is an academic researcher from Radboud University Nijmegen. The author has contributed to research in topics: Innate immune system & Mycobacterium tuberculosis. The author has an hindex of 17, co-authored 18 publications receiving 2902 citations. Previous affiliations of Johanneke Kleinnijenhuis include Radboud University Nijmegen Medical Centre.

Papers
More filters
Journal ArticleDOI

Bacille Calmette-Guérin induces NOD2-dependent nonspecific protection from reinfection via epigenetic reprogramming of monocytes

TL;DR: It is shown that bacille Calmette-Guérin (BCG) vaccination in healthy volunteers led to a four- to sevenfold increase in the production of IFN-γ, but also to a twofold enhanced release of monocyte-derived cytokines, such as TNF and IL-1β, in response to unrelated bacterial and fungal pathogens.
Journal ArticleDOI

Long-lasting effects of BCG vaccination on both heterologous Th1/Th17 responses and innate trained immunity.

TL;DR: BCG induces sustained changes in the immune system associated with a nonspecific response to infections both at the level of innate trained immunity and at thelevel of heterologous Th1/Th17 responses 1 year after vaccination.
Journal ArticleDOI

Innate immune recognition of Mycobacterium tuberculosis.

TL;DR: Insight into pattern recognition receptors and the recognition of mycobacteria, combined with immunogenetic studies in TB patients, does not only lead to a better understanding of the pathogenesis of tuberculosis but also may contribute to the design of novel immunotherapeutic strategies.
Journal ArticleDOI

BCG-induced trained immunity in NK cells: role for non-specific protection to infection

TL;DR: BCG vaccination of healthy volunteers increased proinflammatory cytokine production following ex vivo stimulation of NK cells with mycobacteria and other unrelated pathogens up until at least three months after vaccination, which suggests that NK cells may contribute to the non-specific (heterologous) beneficial effects of BCG vaccination.